Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer's disease. - Chen Y; Zeng X; Olvera-Rojas M; Sewell KR; Sehrawat A; Gu J; Triviño-Ibañez EM; Solis-Urra P; Gómez-Río M; Oberlin LE; Kramer AF; Hillman CH; et al. (Nature communications, 2026)